Correction to: Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group
Ann Hematol. 2021 Aug;100(8):2141-2142.
doi: 10.1007/s00277-021-04564-2.
1 Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Moorenstr. 5, 40225, Düsseldorf, Germany. Esther.schuler@med.uni-duesseldorf.de.
2 Department of Hematology, Oncology, Pneumology, Medical Clinic III, UCT Johannes Gutenberg-University Mainz, Mainz, Germany.
3 Department of Medicine II, Goethe University, Frankfurt am Main, Germany.
4 Department of Hematology, Oncology, Hemostasiology and Stem Cell Transplantation, Medical Clinic IV, University Hospital RWTH Aachen, Aachen, Germany.
5 Bone Marrow Transplantation Unit, Medical Clinic 5, Nürnberg, Germany.
6 Department of Hematology, Oncology, Immunology, Palliative Care, Munich Clinic Schwabing, Munich, Germany.
7 Medical Clinic III, University Medicine Mannheim, Mannheim, Germany.
8 Department of Hematology and Oncology, Medical Clinic II, University Hospital Augsburg, Augsburg, Germany.
9 Medical Clinic III, University Medicine Regensburg, Regensburg, Germany.
10 Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Moorenstr. 5, 40225, Düsseldorf, Germany.
11 Clinic for Bone Marrow Transplantation, University Hospital Essen, Essen, Germany.
12 Department of Internal Medicine IV, University Hospital Halle, Martin-Luther-University Halle-Wittenberg, Halle, Germany.
13 Department of Internal Medicine I, University Hospital Carl Gustav Carus at the Technische Universität, Dresden, Germany.